Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study

BACKGROUND: Clinical trials investigating the effects of beta-blockers (BBs) on cancer are underway. Evidence from preclinical research suggests that BBs could serve as anticancer agents and immune boosters. There is conflicting evidence regarding the effect of BB use on clinical outcomes in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Hui-Hsia, Wu, Tien-Yuan, Chen, Chi-Hua, Kuo, Yu-Hung, Hour, Mann-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288415/
https://www.ncbi.nlm.nih.gov/pubmed/37359444
http://dx.doi.org/10.1177/20420986231181338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288415/
https://www.ncbi.nlm.nih.gov/pubmed/37359444
http://dx.doi.org/10.1177/20420986231181338

Ejemplares similares